Earlier work also showed that in addition to FcRL5 (a potential inhibitory receptor) the expression of two inhibitory receptors, CD85j and CD22, were upregulated in malaria-associated atypical MBCs as compared to classical MBCs (5). The gene discussed is CD22; the disease is malaria.